Medicare Benefits Schedule Expands To Add Tms Therapy

By Author: Jason Pace
Total Articles: 58
Comment this article

At present, the treatment for transcranial magnetic stimulation (TMS) spans over four weeks and at a cost of $3,500 to $5,000 - this alone isn’t even a full on fix for the issues it tries to resolve.

With many people choosing to take TMS therapy to alleviate the effects of their disorders, such as was the case for a patient who was diagnosed with bipolar disorder, rtms treatment cost are not cheap as we’ve explained before and even more so with the maintenance sessions that need to be done in the following months and years.

Some doctors from the Black Dog Institute, who led the first set of Australian randomised controlled trials of TMS back in 1997, even stated that TMS therapy was like an expansion of an entirely new field of treatments with its own field in psychiatry.

With their understanding of the treatment since then improving, they’ve gone on to find a balance between rtms treatment cost and availability over the decades but as of 2021, TMS Australia has found itself in a tied situation regarding the Medicare funding of Australia.

With no Medicare funding in Australia, plenty of those ...
... needing TMS have been availing for it in hospitals and end up being housed in for four weeks of the treatment when other patients might need it more direly.

TMS Australia has been lobbying to have rTMS added to the Medicare Benefits Schedule (MBS) since 2012, as the funding will allow the treatment to be more accessible to those without private health insurance or cannot keep up with hospital fees.

Not to mention how much more beneficial it could be for the 50 to 60 people with depression who have tried and failed to receive benefit from medications that are treated as alternatives for TMS. The main benefit of TMS as well is how compared to other alternatives such as electroshock therapy, it is essentially painless, and isn’t associated with any possible memory issues.

With the explained rtms treatment cost mentioned earlier, the reason for such a cost is because TMS is unique in a way that they can target the known regions of a patient’s brain that they know are not functioning properly. A complete difference from other medications that will affect other regions as well.

It is the hope of TMS Australia that setting it apart from other treatment options, while also making it more accessible outside of hospital walls, can better aid patients and even potentially change their lives for the better with this one step.

Depression is common. More than 264 million people of all ages around the world suffer from depression.